1001 related articles for article (PubMed ID: 12682237)
41. Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry.
Cornberg M; Sheridan BS; Saccoccio FM; Brehm MA; Selin LK
J Virol; 2007 Jan; 81(2):934-44. PubMed ID: 17079318
[TBL] [Abstract][Full Text] [Related]
42. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
Matloubian M; Concepcion RJ; Ahmed R
J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595
[TBL] [Abstract][Full Text] [Related]
43. CD4 T cell-dependent CD8 T cell maturation.
Khanolkar A; Fuller MJ; Zajac AJ
J Immunol; 2004 Mar; 172(5):2834-44. PubMed ID: 14978084
[TBL] [Abstract][Full Text] [Related]
44. Expression and functional importance of collagen-binding integrins, alpha 1 beta 1 and alpha 2 beta 1, on virus-activated T cells.
Andreasen SØ; Thomsen AR; Koteliansky VE; Novobrantseva TI; Sprague AG; de Fougerolles AR; Christensen JP
J Immunol; 2003 Sep; 171(6):2804-11. PubMed ID: 12960301
[TBL] [Abstract][Full Text] [Related]
45. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
[TBL] [Abstract][Full Text] [Related]
46. Selective delivery of augmented IL-2 receptor signals to responding CD8+ T cells increases the size of the acute antiviral response and of the resulting memory T cell pool.
Cheng LE; Greenberg PD
J Immunol; 2002 Nov; 169(9):4990-7. PubMed ID: 12391213
[TBL] [Abstract][Full Text] [Related]
47. Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response.
Zarozinski CC; Welsh RM
J Exp Med; 1997 May; 185(9):1629-39. PubMed ID: 9151900
[TBL] [Abstract][Full Text] [Related]
48. Depletion of CD4+ T cells precipitates immunopathology in immunodeficient mice infected with a noncytocidal virus.
Christensen JP; Bartholdy C; Wodarz D; Thomsen AR
J Immunol; 2001 Mar; 166(5):3384-91. PubMed ID: 11207295
[TBL] [Abstract][Full Text] [Related]
49. A novel approach to visualize polyclonal virus-specific CD8 T cells in vivo.
Zimmermann C; Pircher H
J Immunol; 1999 May; 162(9):5178-82. PubMed ID: 10227990
[TBL] [Abstract][Full Text] [Related]
50. Intestinal intraepithelial lymphocytes respond to systemic lymphocytic choriomeningitis virus infection.
Sydora BC; Jamieson BD; Ahmed R; Kronenberg M
Cell Immunol; 1996 Feb; 167(2):161-9. PubMed ID: 8603424
[TBL] [Abstract][Full Text] [Related]
51. Immunoproteasome-deficient mice mount largely normal CD8+ T cell responses to lymphocytic choriomeningitis virus infection and DNA vaccination.
Nussbaum AK; Rodriguez-Carreno MP; Benning N; Botten J; Whitton JL
J Immunol; 2005 Jul; 175(2):1153-60. PubMed ID: 16002717
[TBL] [Abstract][Full Text] [Related]
52. In vivo modulation of T cell responses and protective immunity by TCR antagonism during infection.
Lau LL; Jiang J; Shen H
J Immunol; 2005 Jun; 174(12):7970-6. PubMed ID: 15944303
[TBL] [Abstract][Full Text] [Related]
53. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
[TBL] [Abstract][Full Text] [Related]
54. Virus-induced polyclonal cytotoxic T lymphocyte stimulation.
Yang HY; Dundon PL; Nahill SR; Welsh RM
J Immunol; 1989 Mar; 142(5):1710-8. PubMed ID: 2537363
[TBL] [Abstract][Full Text] [Related]
55. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.
Wherry EJ; Blattman JN; Murali-Krishna K; van der Most R; Ahmed R
J Virol; 2003 Apr; 77(8):4911-27. PubMed ID: 12663797
[TBL] [Abstract][Full Text] [Related]
56. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
Slifka MK; Pagarigan R; Mena I; Feuer R; Whitton JL
J Virol; 2001 Mar; 75(5):2377-87. PubMed ID: 11160741
[TBL] [Abstract][Full Text] [Related]
57. Allografts stimulate cross-reactive virus-specific memory CD8 T cells with private specificity.
Brehm MA; Daniels KA; Priyadharshini B; Thornley TB; Greiner DL; Rossini AA; Welsh RM
Am J Transplant; 2010 Aug; 10(8):1738-48. PubMed ID: 20659086
[TBL] [Abstract][Full Text] [Related]
58. In vivo state of antiviral CTL precursors. Characterization of a cycling cell population containing CTL precursors in immune mice.
Razvi ES; Welsh RM; McFarland HI
J Immunol; 1995 Jan; 154(2):620-32. PubMed ID: 7529281
[TBL] [Abstract][Full Text] [Related]
59. Antiviral CD4 and CD8 T-cell memory: differences in the size of the response and activation requirements.
Whitmire JK; Murali-Krishna K; Altman J; Ahmed R
Philos Trans R Soc Lond B Biol Sci; 2000 Mar; 355(1395):373-9. PubMed ID: 10794058
[TBL] [Abstract][Full Text] [Related]
60. Peptide vaccination of mice immune to LCMV or vaccinia virus causes serious CD8 T cell-mediated, TNF-dependent immunopathology.
Liu F; Feuer R; Hassett DE; Whitton JL
J Clin Invest; 2006 Feb; 116(2):465-75. PubMed ID: 16424939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
